Health Condition 1: B369- Superficial mycosis, unspecified
Conditions
Interventions
None listed
Sponsors
SKM Siddha and Ayurveda Company India Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1 Male female patients aged = 18 years and =65 years at the time of consent 2 Patients who are recently diagnosed for dermal fungal infection and treatment naive 3 Patients who are willing to give voluntary written informed consent
Exclusion criteria
Exclusion criteria: 1. Patients with allergies to cosmetics, moisturizers, and whitening/bleaching agents. 2. Patients who have sunburn, chapped, or irritated skin or open wounds; 3. Patients with history of skin cancer or treatment for any type of cancer and use of immunosuppressive medication within past 2 years; 4.Patients with terminally ill and any other condition in the opinion of the investigator which would affect the safety of the patient 5 Patients who are not willing to discontinue any other personal care products containing whitening bleaching properties during the study period 6 Female patients who are breast feeding pregnant or intends to become pregnant during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment-emergent Adverse events (TEAEs) (serious/nonserious, expected/unexpected, related/non-related).Timepoint: Day 1,Day 14,Day 21,Day 51 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Complete cure rate - Change in Six Area Six Sign Atopic Dermatitis score (SASSAD) 2.Change in Dermatology Life Quality Index (DLQI) Questionnaire score 3.Change in Patient Global Assessment of Disease StatusTimepoint: Day 1,Day 14,Day 21,Day 51 | — |
Countries
India
Contacts
Public ContactBrindha Arumugam
SKM Siddha and Ayurveda Company India Private Limited
Outcome results
None listed